Innovator Purdue Pharma and generics player Mallinckrodt have struck a deal that will allow Mallinckrodt to market and sell its cheaper version of the brand-name painkiller OxyContin (4, 5-epoxy-14-hydroxy-3- methoxy-17-methylmorphinan-6-one) for a licensing fee.
Innovator got approval on December 12, 1995 for marketing 15 10, 20, 30, 40, 80, 60 mg/tablet Extended release tablets
No comments:
Post a Comment